It has been reported that the circulating level of adiponectin is lowered in obesity, and adiponectin treatment decreases hyperglycemia and improves insulin sensitivity by acting on skeletal muscle and the liver [36]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.